AI assistant
Sending…
Dare Bioscience, Inc. — Director's Dealing 2017
Jul 21, 2017
34825_dirs_2017-07-21_489e52d2-512a-454e-9cc2-484ea0b69d30.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Dare Bioscience, Inc. (DARE)
CIK: 0001401914
Period of Report: 2017-07-19
Reporting Person: Walters-Hoffert Lisa (Chief Financial Officer)
More from Dare Bioscience, Inc.
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
Jun 1
Capital/Financing Update
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 22
Board/Management Information
2026
Apr 17
Capital/Financing Update
2026
Apr 13